Relypsa, Inc. to Present Phase 3 Data in Late-Breaking Poster Session at ASN Kidney Week 2013 Annual Meeting in Atlanta, GA
10/21/2013 7:18:34 AM
Relypsa, Inc., a clinical-stage biopharmaceutical company, today announced that the American Society of Nephrology (ASN) has accepted its abstract for the late-breaking clinical trial poster session of the ASN Kidney Week 2013 Annual Meeting in Atlanta, GA.
Help employers find you! Check out all the jobs and post your resume.
comments powered by